All coverage
Industry fights over global vaccine patents are just warming up
By Christopher Rowland
TRIPS waiver: there's more to the story than vaccine patents
By Siva Thambisetty, Hyo Yoon Kang & Jocelyn Bosse
Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
By Madeline Chambers, Andreas Rinke & Douglas Busvine
All you need to know about the battle over COVID jab IP rights
By Virginia Pietromarchi
Biden Backs Waiving International Patent Protections For COVID-19 Vaccines
By Emma Bowman & Ashish Valentine
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive
By Helen Branswell, Matthew Herper & Damian Garde
Explained: Intellectual property waiver for Covid-19 vaccines
By Aanchal Magazine & Prabha Raghavan
U.S. Backs Waiver of Intellectual Property Protection for Covid-19 Vaccines
By Jared S. Hopkins & Yuka Hayashi
U.S. backs waiving patent protections for Covid vaccines, citing global health crisis
By Thomas Franck, Amanda Macias & Kevin Breuninger
Covid: The vaccine patent row explained
By Dharshini David
U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech
By David Lawder, Andrea Shalal-Esa & Carl O'Donnell
Explainer: COVID-19 vaccine patents dominate global trade talks
By Philip Blenkinsop
U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents
By Jeff Mason, Andrea Shalal-Esa & David Lawder
Biden administration to waive vaccine patent protection
By Dan Diamond, Tyler Pager & Jeff Stein